Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LGND will decline by -3.36% over the next 2 Weeks and hit $177.79 by Friday, March 6, 2026. In that time frame, LGND's share price is expected to range between $172.39 and $183.25.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 6, 2026 | 171.70 | 177.48 | 182.94 |
| Mar 5, 2026 | 173.29 | 178.78 | 184.00 |
| Mar 4, 2026 | 173.87 | 179.05 | 184.66 |
| Mar 3, 2026 | 173.15 | 178.66 | 184.60 |
| Mar 2, 2026 | 175.95 | 181.80 | 187.17 |
| Feb 27, 2026 | 175.02 | 180.73 | 186.45 |
| Feb 26, 2026 | 176.39 | 182.03 | 187.29 |
| Feb 25, 2026 | 176.29 | 182.30 | 187.56 |
| Feb 24, 2026 | 176.50 | 181.91 | 187.93 |
| Feb 23, 2026 | 179.60 | 185.05 | 190.81 |
LGND shares fell -1.26% in Friday, February 20, 2026's trading session, dropping from a previous close of $186.32 to move at $183.98. The stock demonstrated notable intraday movement (see LGND's key stats for a full breakdown), fluctuating between $182.51 and $186.79, a +2.35% trading range. While recent weeks have seen some volatility, LGND has managed to secure a -3.39% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 146.43K shares changing hands, 11.72K more than the previous session. This amounted to $26.94M in total market activity.
Will LGND Continue Its Downward Trend?
According to analyst ratings and projections for LGND, Ligand Pharmaceuticals Incorporated shares are anticipated to decrease by -0.57%, potentially reaching $182.94 per share by March 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for LGND. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the LGND stock forecast, now is not the best time to buy LGND stock because its current trading price is +3.66% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LGND covering social and institutional perspectives.
LGND Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LGND's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.78% to 43.30%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.26%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.85%, maintains a neutral outlook for the long term. Insights into LGND's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ligand Pharmaceuticals Short-Term Forecasts
LGND Forecast For Next 5 Days
Our algorithm anticipates Ligand Pharmaceuticals (LGND) stock could hit $177.62 by Feb 27, 2026. This represents a -3.46% fall from today's price, following a -4.96% change over the past five days.
LGND Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Ligand Pharmaceuticals Incorporated (LGND) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $177.71, which would mean a -3.41% decrease from the current price of $183.98. Projections for this period range from a high of $192.49 to a low of $162.73.
LGND Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Ligand Pharmaceuticals's price over the next three months point to a rise. LGND stock is expected to peak at $203.39 on May 13, 2026 after potentially dipping to $175.49 on Feb 23, 2026. On average, LGND is likely to trade around $190.79 in the coming 90 days.
Ligand Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Ligand Pharmaceuticals (LGND) is expected to trade between $175.49 and $255.64 throughout 2026. This would result in an average price of $203.29, potentially offering investors a +10.50% return from current levels.
Ligand Pharmaceuticals Incorporated Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in February 2026. The price is predicted to move between $175.49 and $194.00, settling at an average of $184.91. This could translate to a +0.51% gain.
March 2026
Based on current market signals, Ligand Pharmaceuticals Incorporated is projected to trend march 2026. We forecast a trading range from $177.92 to $198.62, with a likely average price of $188.15. Investors could expect a potential return of +2.27%.
April 2026
Our predictive algorithms indicate Ligand Pharmaceuticals Incorporated stock may see a shift in April 2026. The expected range spans $181.51–$203.21, with an average target of $192.29. This represents a positive outlook and a possible gain of +4.52%.
May 2026
Analyzing established trends, Ligand Pharmaceuticals Incorporated looks set to move in May 2026. Projections place the stock between $184.48 and $203.39, averaging around $194.28. This suggests a +5.60% gain from current levels.
June 2026
Market indicators suggest Ligand Pharmaceuticals Incorporated could experience notable changes during June 2026. Prices could fluctuate within $188.89 to $210.65, with a midpoint forecast of $200.18. The stock might deliver a +8.81% gain.
July 2026
Forecasting for July 2026, models estimate that Ligand Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $191.55 and $212.19, averaging $201.34. This signals a positive trajectory with potential returns around +9.44%.
August 2026
According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in August 2026. The price is predicted to move between $193.48 and $214.72, settling at an average of $204.72. This could translate to a +11.27% gain.
September 2026
Based on current market signals, Ligand Pharmaceuticals Incorporated is projected to trend september 2026. We forecast a trading range from $198.13 to $219.34, with a likely average price of $208.80. Investors could expect a potential return of +13.49%.
October 2026
Our predictive algorithms indicate Ligand Pharmaceuticals Incorporated stock may see a shift in October 2026. The expected range spans $201.50–$220.46, with an average target of $210.94. This represents a positive outlook and a possible gain of +14.65%.
November 2026
Analyzing established trends, Ligand Pharmaceuticals Incorporated looks set to move in November 2026. Projections place the stock between $206.32 and $255.64, averaging around $218.45. This suggests a +18.74% gain from current levels.
December 2026
Market indicators suggest Ligand Pharmaceuticals Incorporated could experience notable changes during December 2026. Prices could fluctuate within $207.89 to $228.90, with a midpoint forecast of $217.72. The stock might deliver a +18.34% gain.
January 2027
Forecasting for January 2027, models estimate that Ligand Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $210.30 and $232.45, averaging $221.30. This signals a positive trajectory with potential returns around +20.28%.
February 2027
According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in February 2027. The price is predicted to move between $214.49 and $235.23, settling at an average of $224.91. This could translate to a +22.25% gain.
LGND's history of dividends and stock splits also plays a role in long-term investor confidence.